BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16462155)

  • 21. Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens.
    Mazzucchelli R; Barbisan F; Tarquini LM; Filosa A; Campanini N; Galosi AB
    Anal Quant Cytol Histol; 2005 Jun; 27(3):125-33. PubMed ID: 16121633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current perspectives on the Gleason grading of prostate cancer.
    Shah RB
    Arch Pathol Lab Med; 2009 Nov; 133(11):1810-6. PubMed ID: 19886716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study between prostatic carcinoma G1-G3 and Gleason grading systems.
    Zaharia B; Pleşea IE; Enache SD; Tomescu P; Panuş A; Pop OT; Badea P; Kozokić A
    Rom J Morphol Embryol; 1999-2004; 45():185-97. PubMed ID: 15847394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of the 2005 International Society of Urological Pathology Gleason Grading System in prostate biopsy and radical prostatectomy specimens.
    Trpkov K; Zhang J
    BJU Int; 2009 Sep; 104(5):722-3. PubMed ID: 19689580
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of increased number of biopsies on the nature of prostate cancer identified.
    Meng MV; Elkin EP; DuChane J; Carroll PR
    J Urol; 2006 Jul; 176(1):63-8; discussion 69. PubMed ID: 16753368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression.
    Trpkov K; Zhang J; Chan M; Eigl BJ; Yilmaz A
    Am J Surg Pathol; 2009 Feb; 33(2):233-40. PubMed ID: 18936690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
    J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
    Pinthus JH; Witkos M; Fleshner NE; Sweet J; Evans A; Jewett MA; Krahn M; Alibhai S; Trachtenberg J
    J Urol; 2006 Sep; 176(3):979-84; discussion 984. PubMed ID: 16890675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.
    Kvåle R; Møller B; Wahlqvist R; Fosså SD; Berner A; Busch C; Kyrdalen AE; Svindland A; Viset T; Halvorsen OJ
    BJU Int; 2009 Jun; 103(12):1647-54. PubMed ID: 19154461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
    Miyamoto H; Hernandez DJ; Epstein JI
    Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
    Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M
    Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens.
    Fine SW; Amin MB; Berney DM; Bjartell A; Egevad L; Epstein JI; Humphrey PA; Magi-Galluzzi C; Montironi R; Stief C
    Eur Urol; 2012 Jul; 62(1):20-39. PubMed ID: 22421083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR; Yu X; Loeb S; Desireddi VN; Han M; Graif T; Catalona WJ
    J Urol; 2007 Sep; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.